1 |
Evoli A. Clinical aspects of neuromuscular transmission disorders[J]. Acta Neurol Scand Suppl,2006,183:8-11.
|
2 |
Carrieri PB, Marano E, Perretti A,et al. The thymus and myasthenia gravis:immunological and neurophysiological aspects[J]. Ann Med,1999,31(Suppl 2):S52-S56.
|
3 |
Levinson AI, Zheng Y, Gaulton G,et al. Intrathymic expression of neuromuscular acetylcholine receptors and the immunpathogenesis of myasthenia gravis[J]. Immunol Res,2003,27(2-3):399-408.
|
4 |
Anderson G, Harman BC, Hare KJ,et al. Microenvironmental regulation of T cell development in the thymus[J]. Semin Immunol,2000,12(5):457-464.
|
5 |
Haynes BF, Sempowski GD, Wells AF,et al. The human thymus during aging[J]. Immunol Res,2000,22(2-3):253-261.
|
6 |
Breitfeld D, Ohl L, Kremmer E,et al. Follicular B helper T cells express CXC chemokine receptor 5,localize to B cell follicles,and support immunoglobulin production[J]. J Exp Med,2000,192(11):1545-1552.
|
7 |
Schaerli P, Willimann K, Lang AB,et al. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function[J]. J Exp Med,2000,192(11):1553-1562.
|
8 |
Crotty S. Follicular helper CD4 T cells (TFH)[J]. Annu Rev Immunol,2011,29:621-663.
|
9 |
Cappione A, Anolik JH, Pugh-Bernard A,et al. Germinal center exclusion of auto-reactive B cells is defective in human systemic lupus erythematosus[J]. J Clin Invest,2005,115(11):3205-3216.
|
10 |
Yanaba K, Bouaziz JD, Matsushita T,et al. B-lymphocyte contributions to human autoimmune disease[J]. Immunol Rev,2008,223:284-299.
|
11 |
Li S, Liao W, Chen M,et al. Expression of programmed death-1 (PD-1) on CD4+ and CD8+ T cells in rheumatoid arthritis[J]. Inflammation,2014,37(1):116-121.
|
12 |
Zhang L, Wang Y, Shi X,et al. A higher frequency of CD4+CXCR5+ T follicular helper cells in patients with newly diagnosed IgA nephropathy[J]. Immunol Lett,2014,158(1-2):101-108.
|
13 |
Morita R, Schmitt N, Bentebibel SE,et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion[J]. Immunity,2111,34(1):108-121.
|
14 |
Yang X, Yang J, Chu Y,et al. T follicular helper cells and regulatory B cells dynamics in systemic lupus erythematosus[J]. PLoS One,2014,9(2):e88441.
|
15 |
Liu Y, Zhao P, Qu, Z,et al. Frequency of CD4+CXCR5+ TFH cells in patients with hepatitis b virus-associated membranous nephropathy[J]. Int Immunopharmacol,2014,22(1):98-106.
|
16 |
Luo C, Li Y, Liu W,et al. Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis[J]. J Neuroimmunol,2013,256(1-2):55-61.
|
17 |
Nurieva RI, Chung Y, Martinez GJ,et al. Bcl6 mediates the development of T follicular helper cells[J]. Science,2009,325(5943):1001-1005.
|
18 |
Cannons JL, Qi H, Lu KT,et al. Optimal germinal center responses require a multistage T cell:B cell adhesion process involving integrins,SLAM-associated protein,and CD84[J]. Immunity,2010,32(2):253-265.
|
19 |
Choi YS, Kageyama R, Eto D,et al. ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6[J]. Immunity,2011,34(6):932-946.
|
20 |
Yu D, Rao S, Tsai LM,et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment[J]. Immunity,2009,31(3):457-468.
|
21 |
Bossaller L, Burger J, Draeger R,et al. ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells[J]. J Immunol,2006,177(7):4927-4932.
|
22 |
Francisco LM, Sage PT, Sharpe AH. The PD-1 pathway in tolerance and autoimmunity[J]. Immunol Rev,2010,236:219-242.
|
23 |
Good-Jacobson KL, Szumilas CG, Chen L,et al. PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells[J]. Nat Immunol,2010,11(6):535-542.
|
24 |
Gianchecchi E, Delfino DV, Fierabracci A. Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity[J]. Autoimmun Rev,2013,12(11):1091-1100.
|
25 |
Kristjansdottir H, Steinsson K, Gunnarsson I,et al. Lower expression levels of the programmed death 1 receptor on CD4+CD25+ T cells and correlation with the PD-1.3A genotype in patients with systemic lupus erythematosus[J]. Arthritis Rheum,2010,62(6):1702-1711.
|